Nicotinamide riboside | Multichem R&D

Viral infection as an NAD+ battlefield

Charles Brenner

Published on 03 January 2022

Topics:

Nicotinamide riboside

Read more about Viral infection as an NAD+ battlefield

NAD+ in COVID-19 and viral infections

Minyan Zheng, Michael B. Schultz, and David A. Sinclair

Published on February 10, 2022

Topics:

NMN [nicotinamide monocleotide]

Nicotinamide riboside

Read more about NAD+ in COVID-19 and viral infections

Understanding the immune response in COVID-19 – new opportunities and new insights

Professor Guy Richards - Charlotte Maxeke Academic Hospital, Johannesburg

Published on July 2021

Topics:

Nicotinamide riboside

Read more about Understanding the immune response in COVID-19 – new opportunities and new insights